Skip to main content
Nathan B. Fountain

Nathan B. Fountain

Professor, Neurology

Primary Location
PO Box 800394
Primary Phone Number

Bio & Overview

The Epilepsy Clinical Trials Clinic conducts investigator-initiated clinical trials of anti-seizure medications and other interventions sponsored by foundations, NIH, or industry grants. The program concentrates on early phase clinical trials for pharmacokinetics, safety, and proof of principle, but later phase studies are also conducted. The Clinical Epilepsy Database collects clinical information that is available for research into seizure frequency, diagnostic testing, and outcomes research.

Academic Information

Department
Neurology

Research Interests

Clinical development of anti-seizure medications and devices, clinical neurophysiology

Selected Publications

2026

2025

2024

An end-to-end deep learning pipeline to derive blood input with partial volume corrections for automated parametric brain PET mapping
Biomedical Physics & Engineering Express. 2024; 10(5): 055028. DOI:10.1088/2057-1976/AD6A64.

Analysis of seizure‐cluster circadian periodicity from a long‐term, open‐label safety study of diazepam nasal spray
Epilepsia. 2024; 65(4): 920 - 928. DOI:10.1111/EPI.17911.

Developing optimized physical activity interventions for drug-resistant epilepsy: Challenges and lessons learned from a remote exercise intervention pilot trial
Epilepsy & Behavior Reports. 2024; 27: 100693. DOI:10.1016/J.EBR.2024.100693.

Epilepsy monitoring unit practices and safety among NAEC epilepsy centers: A census survey
Epilepsy and Behavior. 2024; 150: 109571. DOI:10.1016/J.YEBEH.2023.109571.

Preclinical toxicity studies supporting 2DG for treatment of status epilepticus
Epilepsy and Behavior. 2024; 160: 110004. DOI:10.1016/J.YEBEH.2024.110004.

Sensitivity of 1st EEG in Detecting Generalized Spike and Wave Activity in Absence Epilepsy (P11-1.004)
Neurology. 2024; 102(7_supplement_1):. DOI:10.1212/WNL.0000000000206693.

2023

2DG and glycolysis as therapeutic targets for status epilepticus
Epilepsy and Behavior. 2023; 140: 109108. DOI:10.1016/J.YEBEH.2023.109108.

A phase 1 open‐label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy
Epilepsia. 2023; 64(4): 831 - 842. DOI:10.1111/EPI.17535.

A single-center survey on physical activity barriers, behaviors and preferences in adults with epilepsy
Epilepsy & Behavior. 2023; 149: 109491. DOI:10.1016/J.YEBEH.2023.109491.

Association Between Characteristics of National Association of Epilepsy Centers and Reported Utilization of Specific Surgical Techniques
Neurology. 2023; 100(7):. DOI:10.1212/WNL.0000000000201526.

Associations between testing and treatment pathways in lesional temporal or extratemporal epilepsy: A census survey of NAEC center directors
Epilepsia. 2023; 64(4): 821 - 830. DOI:10.1111/EPI.17512.

DOPAMINERGIC OVERDRIVE: RESTLESS LEG SYNDROME TREATMENT CAUSING IMPULSE CONTROL DISORDER
Chest. 2023; 164(4 (Supp.)): A6361 - A6362. DOI:10.1016/J.CHEST.2023.07.4098.

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial
Archives of Neurology. 2023; 80(11): 1145. DOI:10.1001/JAMANEUROL.2023.3542.

Epilepsy center characteristics and geographic region influence presurgical testing in the United States
Epilepsia. 2023; 64(1): 127 - 138. DOI:10.1111/EPI.17452.

Multifocal hypometabolic correlates to deficits of verbal memory in mesial temporal lobe epilepsy
Epilepsy and Behavior. 2023; 143: 109244. DOI:10.1016/J.YEBEH.2023.109244.

Time‐to‐event clinical trial designs: Existing evidence and remaining concerns
Epilepsia. 2023; 64(7): 1699 - 1708. DOI:10.1111/EPI.17621.

2022

A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children
Expert Review of Neurotherapeutics. 2022; 22(1): 1 - 13. DOI:10.1080/14737175.2021.2001328.

Association of ultra‐rare coding variants with genetic generalized epilepsy: A case–control whole exome sequencing study
Epilepsia. 2022; 63(3): 723 - 735. DOI:10.1111/EPI.17166.

Competency‐based EEG education: a list of “must‐know” EEG findings for adult and child neurology residents
Epileptic Disorders. 2022; 24(5): 979 - 982. DOI:10.1684/EPD.2022.1476.

Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years
Epilepsia. 2022; 63(10): 2664 - 2670. DOI:10.1111/EPI.17366.

Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
Neurology. 2022; 98(19):. DOI:10.1212/WNL.0000000000200285.

United States Epilepsy Center Characteristics: A Data Analysis From the National Association of Epilepsy Centers
Neurology. 2022; 98(5):. DOI:10.1212/WNL.0000000000013130.

2021

Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial
Archives of Neurology. 2021; 78(3): 285. DOI:10.1001/JAMANEUROL.2020.4607.

Diverse genetic causes of polymicrogyria with epilepsy
Epilepsia. 2021; 62(4): 973 - 983. DOI:10.1111/EPI.16854.

Dynamic FDG-PET in localization of focal epilepsy: A pilot study
Epilepsy and Behavior. 2021; 122: 108204. DOI:10.1016/J.YEBEH.2021.108204.

Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High‐Dose Intravenous Administration in Young Children With Benzodiazepine‐Refractory Status Epilepticus
Journal of Clinical Pharmacology. 2021; 61(6): 763 - 768. DOI:10.1002/JCPH.1801.

Early Neurologic Recovery, Practice Pattern Variation, and the Risk of Endotracheal Intubation Following Established Status Epilepticus
Neurology. 2021; 96(19):. DOI:10.1212/WNL.0000000000011879.

Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial
Epilepsia. 2021; 62(3): 795 - 806. DOI:10.1111/EPI.16825.

PND9 Exploring Serious Adverse Events Associated With Hospitalizations in a Long-term, Phase 3, Open-Label, Repeat-Dose, Safety Study of Diazepam Nasal Spray for Patients With Epilepsy
Value in Health. 2021; 24((Supp.)): S159. DOI:10.1016/J.JVAL.2021.04.793.

2020

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial
The Lancet. 2020; 395(10231): 1217 - 1224. DOI:10.1016/S0140-6736(20)30611-5.

Electrocorticographic events from long-term ambulatory brain recordings can potentially supplement seizure diaries
Epilepsy Research. 2020; 161: 106302. DOI:10.1016/J.EPLEPSYRES.2020.106302.

Incidence of seizure exacerbation and injury related to football participation in people with epilepsy
Epilepsy and Behavior. 2020; 104: 106888. DOI:10.1016/J.YEBEH.2019.106888.

Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy
Neurology. 2020; 95(9):. DOI:10.1212/WNL.0000000000010154.

The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus
Epilepsia. 2020; 61(6):. DOI:10.1111/EPI.16534.

2019

Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trial
Epilepsia. 2019; 60(7): 1453 - 1461. DOI:10.1111/EPI.16072.

Lessons from the Established Status Epilepticus Treatment Trial
Epilepsy and Behavior. 2019; 101: 106296. DOI:10.1016/J.YEBEH.2019.04.049.

Quantitative analysis of phenotypic elements augments traditional electroclinical classification of common familial epilepsies
Epilepsia. 2019; 60(11): 2194 - 2203. DOI:10.1111/EPI.16354.

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
New England Journal of Medicine. 2019; 381(22): 2103 - 2113. DOI:10.1056/NEJMOA1905795.

Underdosing of Benzodiazepines in Patients with Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial
Academic Emergency Medicine. 2019; 26(8): 940 - 943. DOI:10.1111/ACEM.13811.

2018

2017

Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data
European Journal of Human Genetics. 2017; 25(7): 894 - 899. DOI:10.1038/EJHG.2017.61.

Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy
Epilepsia. 2017; 58(6): 994 - 1004. DOI:10.1111/EPI.13740.

Brain‐responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas
Epilepsia. 2017; 58(6): 1005 - 1014. DOI:10.1111/EPI.13739.

De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
American Journal of Human Genetics. 2017; 100(1): 179. DOI:10.1016/J.AJHG.2016.12.012.

Earlier seizure onset and longer epilepsy duration correlate with the degree of temporal hypometabolism in patients with mesial temporal lobe sclerosis
Epilepsy Research. 2017; 138: 105 - 109. DOI:10.1016/J.EPLEPSYRES.2017.10.023.

Reducing placebo exposure in trials: Considerations from the Research Roundtable in Epilepsy
Neurology. 2017; 89(14): 1507 - 1515. DOI:10.1212/WNL.0000000000004535.

Ultra-rare genetic variation in common epilepsies: a case-control sequencing study
Lancet Neurology. 2017; 16(2): 135 - 143. DOI:10.1016/S1474-4422(16)30359-3.

2016